Home » Topics » Regulatory » Patents

Patents
RSS

GlaxoSmithKline describes KMO inhibitors

Dec. 12, 2016

Roche and Genentech disclose ERalpha ligands

Dec. 12, 2016

Ortho-McNeil-Janssen Pharmaceuticals and KU Leuven patent dengue viral replication inhibitors

Dec. 12, 2016

ChemoCentryx describes novel C-C chemokine receptor type 2 ligands

Dec. 9, 2016

Universite de Geneve patents 5-aminolevulinic acid derivatives

Dec. 9, 2016

Cadila Healthcare discloses new kappa-opioid receptor agonists

Dec. 9, 2016

Shanghai Institute Materia Medica presents new c-Met inhibitors

Dec. 7, 2016

Beijing Institute of Pharmacology and Toxicology patents CB1 receptor antagonists

Dec. 7, 2016

The University of Athens identifies novel E-NPP 2 inhibitors

Dec. 7, 2016

Takeda describes new Toll-like receptor 4 antagonists

Dec. 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...